Multiple Sclerosis Impact Scale

Abstract

The Multiple Sclerosis Impact Scale (MSIS-29) is a widely utilized, patient-reported outcome measure designed to assess the subjective impact of Multiple Sclerosis (MS) on an individual’s daily life and functioning over the preceding two weeks. This questionnaire focuses specifically on how the disease manifests in terms of physical and psychological limitations.

Scores derived from the MSIS-29 are interpreted directly: higher scores correspond to a greater negative impact of the condition on daily functioning, indicating a poorer overall health status and quality of life for the patient.

Keywords

Multiple Sclerosis Impact Scale, MSIS-29, quality of life, patient-reported outcome measure, physical impact, psychological impact, neurological disorder, daily functioning.

Authors

Hobart J (2001), Hoogervorst ELJ (2004) (Dutch version).

Purpose

The primary purpose of the MSIS-29 is to quantify the subjective burden and impact of Multiple Sclerosis on the patient. It serves as an essential tool for both clinical research and routine clinical practice, allowing healthcare professionals to gain a detailed understanding of how the chronic nature of the disease influences various aspects of a patient’s life, including mobility, general activities, and participation.

It is specifically designed to be sensitive to change, making it suitable for monitoring disease progression or evaluating the efficacy of therapeutic interventions aimed at improving the patient’s Health-Related Quality of Life (HRQoL).

Construct

The MSIS-29 measures the construct of disease impact on Health-Related Quality of Life (HRQoL), viewed through the lens of MS symptomatology. Unlike scales that focus purely on neurological impairment (e.g., EDSS), the MSIS-29 assesses the patient’s perception of how MS symptoms translate into functional limitation and emotional distress.

The scale is structured around two primary dimensions, reflecting the multidimensional nature of MS impact:

• Physical Impact Scale (20 items): Assessing limitations related to mobility, dexterity, fatigue, and general physical functioning.
• Psychological Impact Scale (9 items): Assessing limitations related to mood, cognitive function, social interaction, and emotional well-being.

Validity

The MSIS-29 demonstrates strong evidence of construct validity. Studies have consistently shown moderate to high correlations between the MSIS-29 scores and scores from other established measures of HRQoL, such as the SF-36, particularly its physical functioning subscales. Furthermore, the scale exhibits known-groups validity, successfully distinguishing between patients with varying levels of disease severity (e.g., measured by the Expanded Disability Status Scale, EDSS).

The scale’s content validity is high, as the items were derived directly from patient interviews and expert consensus, ensuring they are relevant to the lived experience of individuals with Multiple Sclerosis. Its cross-cultural validity has also been established through numerous translations and validations, including the Dutch version by Hoogervorst ELJ.

Reliability

The MSIS-29 possesses excellent psychometric properties, particularly regarding reliability. Internal consistency, measured using Cronbach’s alpha, is typically very high, often exceeding 0.90 for the Physical Impact Scale and generally above 0.80 for the Psychological Impact Scale, confirming that items within each subscale measure the same underlying construct.

Test-retest reliability is also robust, indicating stability of the scores over short periods when the patient’s underlying health status is assumed to be constant. This stability makes the MSIS-29 a reliable instrument for longitudinal tracking in clinical trials.

Factor Analysis

Initial development and subsequent validation studies utilized Factor Analysis to confirm the scale’s intended structure. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have consistently supported the two-factor model (Physical Impact and Psychological Impact).

The factor structure confirms that the 20 physical items load strongly onto one factor, and the 9 psychological items load strongly onto a separate, distinct factor. This clear factor structure supports the theoretical framework of the MSIS-29, making it a valuable tool for differential assessment of disease impact.

Instrument

Test Type: Questionnaire (Patient-Reported Outcome Measure).

Format: 29 items administered using a 5-point Likert scale (ranging from 1 = Not at all to 5 = Extremely) assessing impact over the preceding two weeks. Scores are typically transformed to a 0–100 range for each subscale.

Language Available: Original English, Dutch (Hoogervorst ELJ, 2004), and numerous other validated translations globally.

Population Group: Adults and Elderly individuals diagnosed with Multiple Sclerosis.

Age Group: Adults (18+) and elderly populations.

Population Details: Individuals with various forms and stages of Multiple Sclerosis, including those with associated nervous system and sensory limitations. The scale is also sometimes used comparatively in patients with other neurological conditions like ALS, though its primary focus is MS.

Test Methodology: Self-administered survey. Focuses on assessment of Activities, General Limitations, Mobility/Movement, and General Participation, particularly impacting the Head/Neck and Spinal regions.

Keywords

MSIS-29, psychometric properties, disability assessment, neurological disease, physical functioning, psychological distress, outcome measure, clinical assessment.

Authors

Author ORCID Identifier: Not specified in primary source.

Affiliation Email addresses: Not specified in primary source.

Correspondence Address: Not specified in primary source.

Permissions & Fee and Test Year

Original Test Year: 2001 (Hobart J).

Dutch Version Year: 2004 (Hoogervorst ELJ).

Permissions and Fees: Use of the MSIS-29 is generally permitted for non-commercial academic research and clinical use without charge, though users should confirm specific licensing agreements with the copyright holders (usually the original authors or associated research foundations).

Reference’s

Hobart, J. C., Lamping, D. L., Fitzpatrick, R., Riazi, A., Thompson, A. J. (2001). The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain, 124(5), 962–973.

Hoogervorst ELJ (2004). Validation of the Dutch version of the MSIS-29. (Specific journal reference not provided in source data).

The original explanatory form (Toelichtingsformulier) for the Dutch version can be downloaded here: https://scales.arabpsychology.com/wp-content/uploads/instrumenten/MSIS-29-form.pdf

The original measurement instrument (Meetinstrument) for the Dutch version can be downloaded here: https://scales.arabpsychology.com/wp-content/uploads/instrumenten/MSIS-29-meetinstr.pdf

Items of the Multiple Sclerosis Impact Scale

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The specific text of the 29 items of the Multiple Sclerosis Impact Scale was not provided in the source content. The scale consists of 20 items assessing Physical Impact and 9 items assessing Psychological Impact.

The items are designed to assess the degree to which a person has been affected by symptoms of Multiple Sclerosis over the past two weeks, using a 5-point Likert response format.